A Patient’s Diagnosis with HER2+ Metastatic Colorectal Cancer

Video

Patient Elle Charnisky shares the symptoms that led to her diagnosis of HER2+ metastatic colorectal cancer, and the online resources she used for education after.

Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected
      Recent Videos
      Strategies for Monitoring and Managing T-DXd-Related Adverse Effects
      Strategies for Monitoring and Managing T-DXd-Related Adverse Effects
      The Evolving Role of T-DXd in HER2+ Metastatic Breast Cancer
      The Evolving Role of T-DXd in HER2+ Metastatic Breast Cancer
      Optimizing Maintenance Therapy After First-Line Treatment in HER2+ Metastatic Breast Cancer
      Optimizing Maintenance Therapy After First-Line Treatment in HER2+ Metastatic Breast Cancer
      Current Treatment Approaches in HER2+ Metastatic Breast Cancer
      Current Treatment Approaches in HER2+ Metastatic Breast Cancer
      Complex ES-SCLC Case: Tarlatamab Management Through Toxicity to Clinical Benefit
      Complex ES-SCLC Case: Tarlatamab Management Through Toxicity to Clinical Benefit
      Seamless Transitions: Managing the Inpatient to Outpatient Care Continuum
      Seamless Transitions: Managing the Inpatient to Outpatient Care Continuum
      Future Research Priorities: Optimizing Tarlatamab Administration and Toxicity Management
      Future Research Priorities: Optimizing Tarlatamab Administration and Toxicity Management
      Standardized Toxicity Grading: Institutional Protocols for CRS and ICANS
      Standardized Toxicity Grading: Institutional Protocols for CRS and ICANS
      Differential Toxicity Profile: Tarlatamab vs Traditional Cytotoxic Therapies
      Differential Toxicity Profile: Tarlatamab vs Traditional Cytotoxic Therapies
      Nonimmune Adverse Effects: Managing Dysgeusia and Fatigue
      Nonimmune Adverse Effects: Managing Dysgeusia and Fatigue
      Related Content
      Data from part B of the DeFianCe study demonstrate a positive overall response rate trend with sirexatamab plus bevacizumab and chemotherapy.

      Sirexatamab Combo Significantly Improves PFS in MSS CRC Subgroups

      Russ Conroy
      June 28th 2025
      Article

      Data from part B of the DeFianCe study demonstrate a positive overall response rate trend with sirexatamab plus bevacizumab and chemotherapy.

      The approval of sotorasib plus panitumumab is a “welcome step” in KRAS G12C-mutated colorectal cancer, according to Marwan G. Fakih, MD.

      Sotorasib Combo Approval May Address Novel Therapy Need in KRAS G12C+ CRC

      Marwan G. Fakih, MD
      February 24th 2025
      Podcast

      The approval of sotorasib plus panitumumab is a “welcome step” in KRAS G12C-mutated colorectal cancer, according to Marwan G. Fakih, MD.

      Aspirin Does Not Limit Recurrence, Improve Survival in CRC Liver Metastases

      Aspirin Does Not Limit Recurrence, Improve Survival in CRC Liver Metastases

      Tim Cortese
      June 20th 2025
      Article

      Aspirin led to a median disease-free survival of 1.16 years vs 1.35 years with placebo in patients with colorectal cancer liver metastases.

      Oncology pharmacist Jagoda Misniakiewicz, PharmD, discusses the potential efficacy and safety profile of fruquintinib in patients with metastatic CRC.

      Optimizing Metastatic CRC Outcomes Following Fruquintinib Approval

      Jagoda Misniakiewicz, PharmD
      June 10th 2024
      Podcast

      Oncology pharmacist Jagoda Misniakiewicz, PharmD, discusses the potential efficacy and safety profile of fruquintinib in patients with metastatic CRC.

      In patients 39 years and younger, a statistically significant association between colorectal cancer diagnosis and endometriosis was not observed.

      Adverse Sexual Health Outcomes Appear More Likely in Women With CRC

      Roman Fabbricatore
      June 12th 2025
      Article

      In patients 39 years or younger, a statistically significant association between colorectal cancer diagnosis and endometriosis was not observed.

      Counseling received prior to colorectal surgery using 3-dimensional–printed anatomic models reduced mean anxiety scores vs conventional counseling.

      Preoperative Counseling Increases Shared Decision-Making in CRC Surgery

      Roman Fabbricatore
      June 11th 2025
      Article

      Counseling received prior to colorectal surgery using 3-dimensional–printed anatomic models reduced mean anxiety scores vs conventional counseling.